Malignant Melanoma of Skin Stage III
2 clinical trials · Condition
◉ Watch Malignant Melanoma of Skin Stage III
| Record | Firm | Date |
|---|---|---|
| Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma (NCT02142335) | California Cancer Assocaties for Research & Excellence | 2014-03-01 |
| Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study (NCT01973322) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2013-10-08 |
Track Malignant Melanoma of Skin Stage III automatically
Every clearance here is in the API, with alerts when new ones post.